Cite
HARVARD Citation
Hooshmand, B. et al. (2017). Intra-LC microinjection of orexin type-1 receptor antagonist SB-334867 attenuates the expression of glutamate-induced opiate withdrawal like signs during the active phase in rats. Neuroscience letters. pp. 276-281. [Online].